These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The OX40/OX40L Axis Regulates T Follicular Helper Cell Differentiation: Implications for Autoimmune Diseases. Fu N; Xie F; Sun Z; Wang Q Front Immunol; 2021; 12():670637. PubMed ID: 34234777 [TBL] [Abstract][Full Text] [Related]
7. Critical role of OX40 signaling in the TCR-independent phase of human and murine thymic Treg generation. Kumar P; Marinelarena A; Raghunathan D; Ragothaman VK; Saini S; Bhattacharya P; Fan J; Epstein AL; Maker AV; Prabhakar BS Cell Mol Immunol; 2019 Feb; 16(2):138-153. PubMed ID: 29578532 [TBL] [Abstract][Full Text] [Related]
8. Blockade of OX40/OX40L signaling using anti-OX40L alleviates murine lupus nephritis. Zhao J; Li L; Feng X; Yin H; Fan X; Gao C; Zhao M; Lu Q Eur J Immunol; 2024 Aug; 54(8):e2350915. PubMed ID: 38798163 [TBL] [Abstract][Full Text] [Related]
9. OX40, OX40L and Autoimmunity: a Comprehensive Review. Webb GJ; Hirschfield GM; Lane PJ Clin Rev Allergy Immunol; 2016 Jun; 50(3):312-32. PubMed ID: 26215166 [TBL] [Abstract][Full Text] [Related]
10. Targeting OX40 and OX40L for the treatment of autoimmunity and cancer. Redmond WL; Weinberg AD Crit Rev Immunol; 2007; 27(5):415-36. PubMed ID: 18197805 [TBL] [Abstract][Full Text] [Related]
12. Potent Immune Modulation by MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion Protein. Oberst MD; Augé C; Morris C; Kentner S; Mulgrew K; McGlinchey K; Hair J; Hanabuchi S; Du Q; Damschroder M; Feng H; Eck S; Buss N; de Haan L; Pierce AJ; Park H; Sylwester A; Axthelm MK; Picker L; Morris NP; Weinberg A; Hammond SA Mol Cancer Ther; 2018 May; 17(5):1024-1038. PubMed ID: 29545330 [TBL] [Abstract][Full Text] [Related]
13. B cell OX40L supports T follicular helper cell development and contributes to SLE pathogenesis. Cortini A; Ellinghaus U; Malik TH; Cunninghame Graham DS; Botto M; Vyse TJ Ann Rheum Dis; 2017 Dec; 76(12):2095-2103. PubMed ID: 28818832 [TBL] [Abstract][Full Text] [Related]
14. OX40/OX40L in systemic lupus erythematosus: association with disease activity and lupus nephritis. Farres MN; Al-Zifzaf DS; Aly AA; Abd Raboh NM Ann Saudi Med; 2011; 31(1):29-34. PubMed ID: 21245596 [TBL] [Abstract][Full Text] [Related]
15. Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells. Kondo K; Okuma K; Tanaka R; Zhang LF; Kodama A; Takahashi Y; Yamamoto N; Ansari AA; Tanaka Y Hum Immunol; 2007 Jul; 68(7):563-71. PubMed ID: 17584577 [TBL] [Abstract][Full Text] [Related]
16. Central Roles of OX40L-OX40 Interaction in the Induction and Progression of Human T Cell-Driven Acute Graft-versus-Host Disease. Tripathi T; Yin W; Xue Y; Zurawski S; Fujita H; Hanabuchi S; Liu YJ; Oh S; Joo H Immunohorizons; 2019 Mar; 3(3):110-120. PubMed ID: 31240276 [TBL] [Abstract][Full Text] [Related]
17. Regulation of the Function of T Follicular Helper Cells and B Cells in Type 1 Diabetes Mellitus by the OX40/OX40L Axis. Du X; Zhu Y; Lu W; Fu N; Wang Q; Shi B J Clin Endocrinol Metab; 2024 Oct; 109(11):2823-2830. PubMed ID: 38625053 [TBL] [Abstract][Full Text] [Related]
18. The role of OX40 ligand/OX40 axis signalling in atopic dermatitis. Guttman-Yassky E; Croft M; Geng B; Rynkiewicz N; Lucchesi D; Peakman M; van Krinks C; Valdecantos W; Xing H; Weidinger S Br J Dermatol; 2024 Sep; 191(4):488-496. PubMed ID: 38836560 [TBL] [Abstract][Full Text] [Related]